Paranovus Entertainment Technology (NASDAQ:PAVS – Get Free Report) and Upexi (NASDAQ:GRVI – Get Free Report) are both small-cap multi-sector conglomerates companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, risk, earnings, analyst recommendations and profitability. Volatility & Risk Paranovus Entertainment Technology […]
Upexi (NASDAQ:UPXI – Free Report) had its price objective reduced by Alliance Global Partners from $7.00 to $5.00 in a report released on Tuesday morning, MarketBeat Ratings reports. Alliance Global Partners currently has a buy rating on the stock. Upexi Price Performance Shares of NASDAQ:UPXI opened at $1.59 on Tuesday. Upexi has a 52 week […]
PacificHealth Laboratories (OTCMKTS:PHLI – Get Free Report) and Upexi (NASDAQ:UPXI – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Analyst Ratings This is a summary of current recommendations […]
Upexi, Inc. (NASDAQ:UPXI – Free Report) CEO Allan Marshall acquired 24,000 shares of the stock in a transaction that occurred on Wednesday, June 28th. The stock was acquired at an average cost of $2.26 per share, for a total transaction of $54,240.00. Following the completion of the transaction, the chief executive officer now directly owns […]
Upexi, Inc. (NASDAQ:UPXI – Free Report) was the recipient of a significant decrease in short interest in June. As of June 15th, there was short interest totalling 76,400 shares, a decrease of 27.7% from the May 31st total of 105,700 shares. Currently, 0.6% of the shares of the stock are short sold. Based on an […]